← FDA Drug Approvals (Drugs@FDA)
CUVRIOR
NDA · New Drug Application · Sponsor: ORPHALAN · Approved 2022-04-28
Drug application
- FDA Application #
NDA215760- Application type
- New Drug Application
- Brand name
- CUVRIOR
- Generic name
- TRIENTINE TETRAHYDROCHLORIDE
- Active ingredients
- TRIENTINE TETRAHYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ORPHALAN
- Manufacturer
- Orphalan SA
- First approval
- 2022-04-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown